« Previous
Next »
BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 2, Issue 2
, Pages 88-92
, April 2009
Decreasing procedural pain over time of left prefrontal rtms for depression: Initial results from the open-label phase of a multisite trial (OPT-TMS)
References
- Reducing pain and unpleasantness during repetitive transcranial magnetic stimulation. J ECT. 2006;22(4):259–264
- Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208–1216
- Imaging human intra-cerebral connectivity by PET during TMS. Neuroreport. 1997;8(12):2787–2791
- Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci. 1996;8(2):172–180
- . Nimodipine increases CSF somatostatin in affectively ill patients. Neuropsychopharmacol. 1995;13(1):75–83
- . Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry. 2001;50(1):58–61
- Using imaging to target the prefrontal cortex for TMS studies in treatment resistant depression. Dialogues in Clin Neurosci. 2006;8(2):266–268
- . Using Sas PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J Educational Behavioral Stat. 1998;24(4):323–355
- Transcranial magnetic stimulation reduces pain in patients with major depression: a sham-controlled study. J Nerv Ment Dis. 2007;195(5):378–381
- Postoperative left prefrontal repetitive transcranial magnetic stimulation (rTMS) reduces patient-controlled analgesia use. Anesthesiology. 2006;105:557–562
The study was funded by National Institute of Mental Health (NIMH) Grants R01MH069887, R01MH069896, R01MH069895, R01MH069886, and R01MH069929; and equipment support was provided by Neuronetics, Inc. Additional support for the MUSC Brain Stimulation Laboratory comes from the Stanley Foundation, the National Alliance for Research on Schizophrenia and Depression (NARSAD), NIMH Grant K08MH070615 (Dr Nahas), and NINDS Grant K23NS050485 (Dr Borckardt).
Conflicts of Interest: MUSC holds several TMS-related patents. Drs George and Sackeim are advisory board members for Neuronetics, Inc.
PII: S1935-861X(08)00333-1
doi: 10.1016/j.brs.2008.09.001
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 2, Issue 2
, Pages 88-92
, April 2009
